Mode
Text Size
Log in / Sign up
N/A Completed N=402

Post-reimbursement Study to Follow Spinal Neurostimulator Devices for Pain Therapy (French SCS Registry)

Chronic Pain Syndrome
Source: ClinicalTrials.gov NCT01778426 ↗
Enrolled (actual)
402
Serious AEs
22.1%
Results posted
Nov 2018
Primary outcomePrimary: Percentage of Subjects With at Least 50% Pain Relief in the Area of Predominant Pain at 2 Years — 59.1 Percentage of responders

Summary

Observational study to evaluate the long term efficacy of Spinal Cord Stimulation (SCS) over 2 years following SCS implant. This study is requested by French Health Authorities for reimbursement renewal, to maintain reimbursement for SCS in approved indication in France.

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Subjects With at Least 50% Pain Relief in the Area of Predominant Pain at 2 Years
59.1 —
SECONDARY
Percentage of Subjects With at Least 50% Pain Relief in the Area of Non-predominant Pain
46.9; 46.5 —
SECONDARY
Percentage of Subjects With at Least 50% Pain Relief in the Area of Predominant Pain at 1 Year
60.7 —
SECONDARY
Concomitant Pain Relief Medication
59.1; 43.3; 43.9; 61.1; 35.4; 36.4 —
SECONDARY
Dose of Analgesics Level 3 (Morphinics)
90.2; 102.6; 100.3 —
SECONDARY
Patient Satisfaction
89.9; 89.3; 82.0; 81.8; 89.9; 91.4 —
SECONDARY
Return to Work
8; 15 —

Eligibility Criteria

Inclusion Criteria

  • Patient indicated for Spinal Cord Stimulation (pain therapy)
  • Patient implanted for less than 3 months or hospitalized for the implant of a Medtronic neurostimulator including:
  • primary implant with Spinal Cord Stimulation indication and positive test of stimulation or
  • device replacement of a Medtronic neurostimulator used for Pain Therapy
  • Evaluation of usual pain in the back, upper and lower limbs using a visual analogic scale must be available for the 3 days preceding implant.
  • Treatments must also be available
  • Patient read and signed the data release form

Exclusion Criteria

  • Patient declined participation
  • Patient is not available for follow up
  • Stimulation of other body part than spinal
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01778426). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search